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1  | INTRODUC TION
Cushing syndrome (CS) is a rare condition caused by a chronic ex‐
cess of glucocorticoids that affects 2‐5 individuals per million people 
annually. Ten per cent of these cases occur in children.1 Endogenous 
CS is most commonly caused by an adrenocorticotropic hormone 
(ACTH) producing pituitary adenoma, which is called Cushing dis‐
ease (CD).1,2 CD affects about 75% of paediatric CS patients over the 
age of 7.1,3 Endogenous CS can also be caused by an ACTH indepen‐
dent adrenal tumour or an ACTH or corticotropin‐releasing hormone 
(CRH)‐producing ectopic tumour.1,2
Hypercortisolism leads to signs and symptoms including obe‐
sity, growth deceleration, striae, moon face, facial plethora, pos‐
terior cervical fat pad, acanthosis nigricans, menstrual irregularity, 
kidney stones, hypercoagulability, diminished bone health, diabetes 
and hypertension.1,2 Even after cure, individuals with CS may face 
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Summary
Objective: To investigate early signs of cardiovascular arterial remodelling in paediat‐
ric patients with Cushing syndrome (CS) in comparison with normative values from 
healthy children.
Study Design: The metrics used to assess cardiac health were from thoracic aorta 
and	carotid	MRI.	Scans	were	performed	on	18	children	with	CS	(mean:	12.5	±	3.1	years,	
range: 6.0‐16.8 years, 10 female). Pulse wave velocity (PWV), aortic distensibility 
(AD)	and	carotid	intima-media	thickness	(cIMT),	well-validated	measurements	of	car‐
diac compromise, were measured from the images and compared to normative age‐
matched values where available.
Results: Patients with CS had significantly higher PWV compared to age‐adjusted 
normal	 median	 control	 values	 (4.0	±	0.7	m/s	 vs.	 3.4	±	0.2	m/s,	 respectively,	
P = 0.0115). PWV was positively correlated with midnight plasma cortisol (r = 0.56, 
P	=	0.02).	Internal	and	common	cIMT	were	negatively	correlated	with	ascending	AD	
(r	=	−0.75,	P = 0.0022, r	=	−0.69,	P = 0.0068, respectively).
Conclusion: Pulse wave velocity data indicate that paediatric patients with CS have 
early evidence of cardiovascular remodelling. The results suggest the opportunity for 
monitoring as these changes begin in childhood.
K E Y W O R D S
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complications including cognitive challenges, cardiovascular disease 
and recurrence of CS.1,6,7
Cardiovascular complications are the leading cause of death in adult 
patients with CS.9 Adults with CS have been found to have a cardio‐
vascular mortality rate that is 4‐5 times higher than the overall popula‐
tion.9,10,13,14 Even after patients are in remission, risk factors including 
hypertension,	high	low-density	lipoprotein	(LDL)	and	total	cholesterol,	
adiposity, diabetes mellitus, insulin resistance and increased arterial 
rigidity may remain unchanged.6,10,15 Additionally, cardiovascular re‐
modelling may be one of the permanent sequelae of long‐standing CS 
and underscores the importance of early detection and treatment in 
children.16 A recent meta‐analysis of 14 studies of atherosclerosis in 
adult patients with CS showed that CS is significantly associated with 
subclinical markers of atherosclerosis and cardiovascular risk.17
An excess of cortisol is also linked to vascular damage, which may 
lead to cardiovascular complications in CS patients.18	It	has	been	shown	
that adult patients with CS have significantly increased carotid intima‐
media thickness and a higher incidence of well‐defined plaque walls 
than control populations with the same cardiovascular risk factors.6,17 
Furthermore, adult patients with CS had increased left and right ven‐
tricular hypertrophy, and lower left atrial ejection fractions and in‐
creased end‐diastolic left ventricular segmental thickness compared to 
the normal population.11	In	contrast,	only	one	prior	study	specifically	
evaluating cardiovascular involvement in children with CS has been 
published to date.7,8	In	this	prior	study,	a	cohort	of	23	female	paediatric	
patients with CS were shown to have increased blood pressure and 
disadvantageous differences in epicardial fat thickness, intima‐media 
thickness	and	N-terminal	pro-B-type	natriuretic	peptide	compared	to	
a control population.7,8 Cardiovascular remodelling may be one of the 
permanent sequelae of long‐standing CS.10 These findings underscore 
the importance of early detection and treatment in children.
Increased	carotid	intima-media	thickness	(IMT)	reflects	morpho‐
logical changes associated with atherosclerosis and is a strong pre‐
dictor for future clinical cardiovascular events. Previous studies have 
established normal values for carotid artery intima‐media thickness 
and distensibility in paediatric patients, using high‐resolution vascu‐
lar ultrasound.19 A study analysing 43 patients with 16‐79% stenosis 
underwent	both	B-mode	ultrasound	and	high-resolution	MRI	exam‐
inations of their carotid arteries found that there was a very high 
correlation between these two methods of examination.20
Aortic pulse wave velocity (PWV) is a well‐validated clinical 
measure of central arterial stiffness and is predictive of increased 
mortality, coronary heart disease and stroke.21,22 PWV has been an 
accurate measure of cardiac complications in individuals with diabe‐
tes, obesity and end‐stage renal disease.22,25,26 PWV has been used 
to measure aortic stiffness in children in prior studies; however, it 
has not been studied in children with CS.22 Additionally, aortic dis‐
tensibility (AD) has been shown to be a sensitive marker of arterial 
stiffening in children.21 While cardiovascular complications in adults 
with CS have been well documented, less is known about cardiovas‐
cular risk in paediatric patients. The aim of this study was to assess 
early signs of cardiovascular remodelling associated with CS in pae‐
diatric	patients	through	measurements	of	AD,	PWV	and	cIMT.
2  | METHODS
2.1 | Study participants
Patients who were diagnosed with CD and participated in the clini‐
cal	 protocol	 NCT00001595	 at	 the	 National	 Institutes	 of	 Health	
Clinical Center between July 2014 and August 2017 and who under‐
went	thoracic	aorta	and	carotid	MRI	were	included	in	the	analysis.	
The protocol was approved by the Eunice Kennedy Shriver	National	
Institute	 of	 Child	 Health	 and	 Human	 Development	 Institutional	
Review	Board.	Informed	consent	and	assent	were	obtained.	Clinical	
information for all patients including midnight serum cortisol levels, 
plasma ACTH levels, systolic and diastolic z‐scores, body mass index 
(BMI)	z‐scores, height z‐score, blood glucose levels, lipid profiles and 
family history was collected.
The diagnosis of CD was made according to standard clinical 
and biochemical criteria including elevated urinary free cortisol 
(UFC), loss of diurnal serum cortisol rhythm, CRH stimulation test 
consistent with CD and/or suppression of morning cortisol from an 
overnight administration of 8 mg dexamethasone, adjusted for body 
weight.2,3,11,27	Patients	with	pituitary	adenomas	clearly	seen	on	MRI	
underwent transsphenoidal surgery (TSS), while more radiographi‐
cally ambiguous cases underwent inferior petrosal sinus sampling to 
localize the source of ACTH before undergoing TSS. All patients had 
pathological confirmation of an ACTH‐positive pituitary adenoma 
on immunohistochemistry staining.
2.2 | Image acquisition
Thoracic	aorta	and	carotid	artery	MRIs	were	offered	to	all	paedi‐
atric CD patients who were able to tolerate the procedure without 
sedation	and	who	did	not	have	MRI	contraindications	(implanted	
non-MRI	safe	devices	or	foreign	metallic	bodies)	or	claustrophobia.	
Imaging	 was	 done	 on	 a	 3.0	 Tesla	 scanner	 (Trio	 Tim,	 Siemens,	
Munich, Germany) using ECG gating and breath‐holding. A 6‐ele‐
ment body surface coil was used for radiofrequency signal detec‐
tion. Sagittal oblique views of the aortic arch were obtained using 
a black‐blood spin echo sequence (slice thickness, 6 mm; matrix, 
256 × 256) to visualize the aorta. At the level of the pulmonary 
artery bifurcation perpendicular to the aorta, a phase contrast 
gradient echo pulse sequence with through‐plane velocity encod‐
ing acquired velocity data in the ascending and descending aorta. 
The maximal encoding velocity encoding was 150 cm/s; the slice 
thickness was 6 mm, and the temporal resolution used was 20 ms; 
and the matrix was 256 × 192. An aortic cine series was acquired 
at the same slice location using a fast retrospectively gated gra‐
dient echo sequence (slice thickness, 6 mm; matrix, 256 × 256; 
temporal	 resolution,	 20	ms).	 Carotid	 MRIs	 were	 acquired	 using	
dedicated	 carotid	 coils.	 In-plane	 spatial	 resolution	 was	 2	mm;	
cross‐sectional spatial resolution was 0.6 mm. Axial T2‐weighted 
and T1‐weighted slices were acquired from the level of the ca‐
rotid bulb through to the bifurcation of the internal and external 
carotid arteries.
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2.3 | Image analysis
Images	 were	 analysed	 using	 Syngo	 Multimodality	 Workplace	 to	
measure Δx, the distance between the ascending and descending 
aorta measurement locations as measured along an intra‐luminal 
midline.	Medis	QMass	Software	(Leiden,	The	Netherlands)	was	used	
to analyse the phase contrast data and find Δt, the time delay of the 
distal flow curve relative to the proximal flow curve determined by 
the difference in time points at the mid‐points of the systolic up‐
slope of the ascending and descending aorta. PWV was then calcu‐
lated using the equation:
The cross‐sectional areas of the ascending and descending aorta 
were measured. Aortic distensibility was calculated from the maxi‐
mal and minimal cross‐sectional areas and the systolic and diastolic 
blood pressures measured the closest to the time of acquisition of 
the	carotid	MRI	using	the	equation:
Amax and Amin represent the maximum and minimum cross‐sec‐
tional areas of the aorta in mm2. Pmax and Pmin represent the systolic 
and	 diastolic	 blood	 pressures,	 respectively.	 Both	 ascending	 aortic	
distensibility and descending aortic distensibility were calculated 
using this equation.
The acquired data were then compared to control data for 
healthy age‐matched children in the literature using the same im‐
aging modality.28 Medis QPlaque software was used for analysis of 
the carotid images. Automatic regions of interest and segmentation 
of the carotid internal lumen and external vessel wall borders were 
created with manually adjusted assistance. The vessel wall was seg‐
mented into 12 regions, and the vessel thickness value was averaged 
from these regions.
2.4 | Statistical analysis
Data were described by frequency distributions and percentages 
or	 by	 mean	±	standard	 deviation.	 A	 P‐value <0.05 was consid‐
ered statistically significant. Data were assessed for distribu‐
tional assumptions, and either t tests or nonparametric Wilcoxon 
rank‐sum tests compared continuous data between groups. 
Spearman's rank correlations tested the relation between vari‐
ous cardiovascular remodelling measures and clinical features. 
Data	analysis	was	carried	out	using	SAS	v	9.4	(SAS	Institute,	Inc,	
Cary,	NC).
3  | RESULTS
Of	the	total	patient	cohort	enrolled	in	the	protocol	97-CH0076,	a	
subset	of	18	patients	had	thoracic	aorta	MRIs	(n	=	17)	or	carotid	
MRI	 (n	=	15)	 and	were	 analysed.	 Patient	 clinical	 characteristics	
are summarized in Table 1. The mean age of the patients at eval‐
uation	was	12.5	±	3.1	years	 old	with	 a	 range	of	 6.0-16.8	years,	
and there were 10 (56%) females and 7 males. The majority of 
the patients were Caucasian (15 patients, 83%), two patients 
were African American and one patient was Asian. The con‐
trol population consisted of 71 children and young adults age 
16.4	±	7.6	years,	 range	 2.3-28.3	years.	 There	 were	 41	 females	
(58%)	and	30	males.	The	BMI	of	the	total	control	population	was	
19.4	±	3.5	kg/m2.
Children	with	CS	had	an	average	PWV	of	4.0	±	0.7	m/s,	while	the	
respective	age-	and	sex-adjusted	normal	value	was	3.4	±	0.2	m/s.	The	
difference between PWV values for CS patient and normal popula‐
tions	was	statistically	significant	(delta	0.59	±	0.86	m/s,	P = 0.0115). 
PWV=Δx∕Δt
Distensibility (10−3 mmHg
−1
) = (Amax − Amin)∕Amin × (Pmax − Pmin)
F I G U R E  1   Aortic pulse wave velocity (PWV). The distance 
between the ascending and descending aorta, Δx, was measured 
along the midline through the aortic arch as shown. The transit 
delay, Δt, was determined by the difference in time points at the 
mid‐points of the systolic upslope of the ascending and descending 
aorta as shown. PWV was calculated as Δx/Δt. Cross‐sectional 
aortic areas were estimated at the ascending and descending aortas 
and used to calculate PWV and aortic distensibility (AD)
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PWV	in	patients	with	CS	did	not	correlate	with	BMI	z‐score, ACTH, 
UFC,	total	cholesterol,	LDL	cholesterol	or	blood	pressure;	however,	
PWV positively correlated with midnight cortisol levels (rs = 0.56, 
P = 0.018; Figure 2).
Additionally, internal and common carotid artery thickness 
(cIMT)	 was	 measured	 as	 an	 indicator	 of	 cardiovascular	 remod‐
elling	 in	 CS	 patients.	 The	 mean	 internal	 cIMT	 of	 paediatric	 CS	
patients	 was	 0.67	±	0.24	mm	 (n	=	15),	 and	 the	 mean	 common	
cIMT	was	0.67	±	0.15	mm	(n	=	15).	The	average	distensibility	 for	
the descending and ascending aorta in the patients with CS was 
13	±	7×10−3	mm	Hg	and	15	±	8×10−3 mm Hg, respectively. There 
was a statistically significant inverse correlation between ascend‐
ing	 aortic	 distensibility	 and	 both	 the	 internal	 cIMT	 (rs	=	−0.74,	
P	=	0.0022)	 and	 the	 common	 cIMT	 (rs	=	−0.69,	 P = 0.007) 
(Figure 3). Additionally, there was an inverse correlation be‐
tween	the	descending	aortic	distensibility	and	the	 internal	cIMT	
(rs	=	−0.55,	P = 0.0433).
4  | DISCUSSION
This study assessed the cardiovascular complications associated 
with CS in paediatric patients using PWV, carotid arterial intimal 
thickness	and	aortic	distensibility.	Our	findings	suggest	that	paedi‐
atric patients with CS have evidence of early cardiovascular remod‐
elling. This supports the current literature which describes long‐term 
cardiovascular	 remodelling	 as	 a	 sequela	 of	 CS	 in	 adults.	Our	 data	
indicate that cardiovascular remodelling occurs at a much younger 
age than previously shown, with differences from normative data 
seen as young as 6 years of age.
The pathophysiology underlying increased PWV in CS is 
thought to be due to an increase in connective tissue volume; this 
remodelling may not be reversible after cure.18	In	our	study,	PWV	
was significantly higher in patients with CS than the normative 
age‐ and sex‐adjusted values. The increase in PWV may be an 
early indicator of worsened bioelastic function in the aorta, which 
is representative of cardiovascular dysfunction.28 Furthermore, 
PWV was correlated with midnight cortisol levels, suggesting that 
the incidence of cardiovascular complications may be associated 
with	the	severity	of	the	primary	disease.	Our	prior	study	has	spe‐
cifically included midnight cortisol as one factor that is linked to 
disease severity.29 Additionally, the ratio of midnight to morning 
Mean ± SD Normal range
Midnight cortisol 16.1	±	6.8	mcg/dL <4.4	µg/dL
Plasma ACTH 53.0	±	25.8	pg/mL 5-46	pg/mL
Glucose 99.6	±	14.9	mg/dL 74-106	mg/dL
Prevalence of hypertension, 
systolic
38%
Prevalence of hypertension, 
diastolic
17%
Height SDS −0.78	±	1.41
BMI/BMI	z‐score 25.8	±	12.5/1.93	±	0.78
Period of disease before 
diagnosis
2.3	±	1.7	y
Total cholesterol 169.2	±	32.3	mg/dL Acceptable:	<170	mg/dL 
Borderline	high	risk:	
170-199	mg/dL 
Elevated:	≥200	mg/dL
HDL 52.2	±	11.1	mg/dL <35	mg/dL
LDL 96.9	±	29.2	mg/dL Acceptable:	<110	mg/dL 
Borderline	high	risk:	
110-129	mg/dL 
Elevated:	≥130	mg/dL
TA B L E  1   Clinical characteristics of 18 
paediatric patients with Cushing 
syndrome at the time of transsphenoidal 
surgery
F I G U R E  2   Pulse wave velocity (PWV) in 18 paediatric patients 
with Cushing syndrome (CS) was positively correlated with 
midnight cortisol levels
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cortisol levels has also been reported to indicate the extent of hy‐
percortisolemia.30 Previous studies in CS patients have noted the 
difficulty in distinguishing between cardiovascular remodelling 
caused by increased cortisol and metabolic disease.14,31 Patients 
with	CS	have	been	shown	to	have	hypertension,	high	LDL	and	total	
cholesterol, adiposity, diabetes mellitus, insulin resistance and in‐
creased arterial rigidity even after cure.6,10 These manifestations 
of CS are potential causes of cardiovascular complications. Thus, 
the link between CS and cardiovascular remodelling is unsurpris‐
ing due to patient's symptoms that have been associated with both 
CS and cardiovascular complications.
This study was limited by the small size of the patient cohort 
due to the rare nature of CS and movement artefact for some of 
the	patients.	In	addition,	this	study	was	limited	in	that	we	did	not	
have control measurements for patients with the same height, 
weight and metabolic parameters. Previous studies have shown 
that obese children have increased arterial stiffening, especially 
in central arteries.32 Due to the small sample size, additional dif‐
ferences between hypertension and normotensive patients were 
unable to be analysed. Additionally, four patients were taking 
antihypertensive medication at the time of the scan. This could 
have affected the results, though it would be expected that this 
would make the difference between CS patients and the norma‐
tive controls less significant. Thus, the differences seen between 
CS patients and the sex‐ and age‐adjusted children do not take 
into account any of these potential covariates.
In	conclusion,	paediatric	patients	with	CS	are	at	a	higher	risk	of	
cardiovascular complications than the general population. These 
findings indicate the importance of early detection of CS in pae‐
diatric patients to avoid long‐term comorbidities. Furthermore, 
these results indicate that the cardiovascular health of patients 
with CS needs to be followed closely from a young age. Patients 
are continuing to be followed to assess whether cardiovascular re‐
modelling is a long‐term consequence of CS as these children grow 
into adulthood.
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